Envista Holdings Co. (NYSE:NVST) Shares Bought by Two Sigma Advisers LP

Two Sigma Advisers LP increased its holdings in Envista Holdings Co. (NYSE:NVST - Free Report) by 66.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 47,800 shares of the company's stock after acquiring an additional 19,100 shares during the period. Two Sigma Advisers LP's holdings in Envista were worth $922,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. Tidal Investments LLC boosted its position in shares of Envista by 53.9% during the fourth quarter. Tidal Investments LLC now owns 31,307 shares of the company's stock worth $604,000 after buying an additional 10,958 shares during the period. Polar Asset Management Partners Inc. raised its stake in shares of Envista by 27.9% in the fourth quarter. Polar Asset Management Partners Inc. now owns 1,914,799 shares of the company's stock valued at $36,936,000 after acquiring an additional 417,549 shares in the last quarter. Quantinno Capital Management LP raised its stake in shares of Envista by 54.2% in the fourth quarter. Quantinno Capital Management LP now owns 86,056 shares of the company's stock valued at $1,660,000 after acquiring an additional 30,264 shares in the last quarter. LMR Partners LLP acquired a new stake in shares of Envista in the fourth quarter valued at $5,037,000. Finally, Iron Triangle Partners LP raised its stake in shares of Envista by 0.5% in the fourth quarter. Iron Triangle Partners LP now owns 2,200,000 shares of the company's stock valued at $42,438,000 after acquiring an additional 10,631 shares in the last quarter.

Envista Stock Performance

Shares of Envista stock traded down $0.07 on Thursday, hitting $18.69. The stock had a trading volume of 1,189,539 shares, compared to its average volume of 2,567,551. Envista Holdings Co. has a 52-week low of $14.22 and a 52-week high of $23.00. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of -2.88, a P/E/G ratio of 1.27 and a beta of 0.99. The company's 50 day moving average price is $16.75 and its 200 day moving average price is $18.70.

Envista (NYSE:NVST - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.04. The business had revenue of $616.90 million during the quarter, compared to the consensus estimate of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The business's quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.26 EPS. On average, research analysts anticipate that Envista Holdings Co. will post 1 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on NVST shares. New Street Research set a $19.00 price objective on Envista in a research note on Thursday, March 6th. Morgan Stanley set a $16.00 price objective on Envista in a research note on Tuesday, April 15th. Piper Sandler reduced their price objective on Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Baird R W raised Envista from a "hold" rating to a "strong-buy" rating in a report on Tuesday, May 27th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Envista in a report on Thursday, March 6th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.23.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.